Spyre Therapeutics Inc (SYRE)
$96.56 -2.43% Close Oct 30, 2026 Live
Spyre Therapeutics stock today
Spyre Therapeutics closed at $96.56 on October 30, 2026, down 2.43% on the day. Over the past year it returned +298.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $8.38 billion.
$50.00$100.00
NovJan 2026MarMayJulSep
| Period | SYRE | S&P 500 (SPY) |
|---|---|---|
| 1 month | +8.5% | -0.9% |
| 3 months | -4.9% | +2.1% |
| Year to date | +194.7% | +11.7% |
| 1 year | +298.0% | +12.4% |
| 3 years | +726.7% | +88.5% |
| 5 years | -47.2% | +76.0% |
Key statistics
- Market value
- $8.38B
- 52-week range
- $22.18 to $108.92
- Next report
- Nov 3, 2026
About Spyre Therapeutics
Develops small molecule therapies for pain management and neurological conditions.
Sector: Health Care
More on Spyre Therapeutics
- Financials: revenue, earnings and segmentsRevenue -62% in the year to Dec 2023
- Returns: what $1,000 became$1,000 ten years ago is $665.93 today
No forecast, no recommendation. This page describes Spyre Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.